Home > Drug Search >
  • company_query: Alzheon
  •   > 
Drug Filter
Category:
chemistry (22) biology (9)
Status:
Approved (5) NDA Filing (1) BLA Filing (2) Phase Ⅲ (3) Phase Ⅱ (8) Phase Ⅰ (12)
Clinical Stage:
Pending (6) Active (13) Discontinued (7)
Bio-Type:
Recombinant cytokines (7) Recombinant hormone (1) Fusion protein (1)
Indication:
Advanced breast cancer (1) Alzheimer's disease (AD) (2) Anemia (2) Asthma (2) Rectal cancer (1) Chronic obstructive pulmonary disease (COPD) (2) Duchenne muscular dystrophy (DMD) (1) Erectile dysfunction (ED) (2) Erosive esophagitis (EE) (1) Gastroesophageal reflux disease (GERD) (2) HBV infection (3) HCV infection (3) Hypogonadotropic hypogonadism (1) Lung cancer (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (1) Ovulation induction (1) Pancreatic cancer (2) Peptic ulcer (1) Postoperative pain (1) Psoriasis (2) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Soft tissue sarcoma (1) Type 2 diabetes (1) Head and neck cancer (1) Neutropenia (2) Infertility (1) Squamous cell carcinoma of head and neck cancer (SCCHN) (1) Terminate pregnancy (1) Gastrointestinal disorders (1) Hypogonadism (1) Postmenopausal syndrome (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top